Effect of Methods of Platelet Resuspension on Stored Platelets

Similar documents
C o r p o r a t e l i f e i n A n c i e n t I n d i a e x p r e s s e d i t s e l f

IgG blocking: An alternative red cell treatment method for phenotyping

Platelet and Granulocyte Pheresis

F O R M T H R E E K enya C ertificate of Secondary E ducation

MAST ACADEMY OUTREACH. WOW (Weather on Wheels)

The M echanism of Factor VIII Inactivation by H um an Antibodies

CypExpress 3A4 Catalyzed Conversion of Testosterone (TE) to 6β- Hydroxytestosterone (HT)

Human placenta lactogen, HPL ELISA kit

Form and content. Iowa Research Online. University of Iowa. Ann A Rahim Khan University of Iowa. Theses and Dissertations

Rat Advanced Glycation End Products(AGEs) ELISA Kit

Human placenta lactogen (HPL)ELISA Kit. MyBioSource.com. Catalog No. MBS (96T)

RayBio Human Thyroid Peroxidase ELISA Kit

Human Paraneoplastic pemphigus (PNP)antibody ELISA Kit. Catalog No. MBS (96 T)

Human von Willebrand Factor cleavingprotease(vwf-cp) ELISA Kit. Catalog No. MBS (96T)

DRG International Inc., USA Web:

Human papillomavirus,hpv ELISA Kit

MAGBIO MAGBIO. cfkapture 21 Kit (3-5 ml) PROTOCOL Contents. Isolation kit for circulating cell-free DNA from stabilized plasma.

cfkapture 21 Kit (3-5 ml) Isolation kit for circulating cell-free DNA from stabilized plasma PROTOCOL

Nov Julien Michel

A new ThermicSol product

Human Plasmin/Antiplasmin Complex ELISA Kit

RNA Transport. R preps R preps

Human Coagulation Factor X Total Antigen ELISA Kit

Information System Desig

cgmp ELISA Kit (Direct Competitive) Based on Monoclonal Anti-cGMP Antibody

CATALASE ACTIVITY ASSAY KIT KB test (96 well plate)

Manipulating the Anisotropic Structure of Gold Nanostars using Good s Buffers

A L A BA M A L A W R E V IE W

The Ability C ongress held at the Shoreham Hotel Decem ber 29 to 31, was a reco rd breaker for winter C ongresses.

RayBio Nickel Magnetic Particles

Serotonin (Human) ELISA Kit

Fault Tolerant Computing CS 530DL

Canine Erythropoietin,EPO ELISA Kit

GENETIC ALGORlIHMS WITH AN APPLICATION TO NONLINEAR TRANSPORTATION PROBLEMS

Case Study of Electronic Materials Packaging with Poor Metal Adhesion and the Process for Performing Root Cause Failure Analysis

Human Coagulation Factor XII Total Antigen ELISA Kit

MAGBIO MAGBIO. cfkapture 21 Kit (1-2ml) PROTOCOL Contents. Isolation kit for circulating cell-free DNA from stabilized plasma.

RayBio Human IDUA ELISA Kit

NAD + /NADH Assay [Colorimetric]

ab alpha 1 Antitrypsin (SERPINA1) Human ELISA Kit

Human Mullerian Inhibiting Substance/Anti-Mullerian hormone (MIS/AMH)Elisa Kit

RayBio Human CA-125 ELISA Kit

Rabbit IgA ELISA Kit

Mag-Bind Soil DNA Kit. M preps M preps M preps

Mouse Cholecystokinin (CCK) ELISA Kit

ab83360 Ammonia Assay Kit

RUO. DRG Amyloid beta Auto-Ab (serum) As of 14 Dec rm (Vers. 1.1)

Fish superoxide dismutase (SOD) ELISA Kit

NucView TM 488 Caspase-3 Assay Kit for Live Cells

U.S. Patent No. 9,051,563 and other pending patents. Ver

Bovine creatine kinase M-type (CKM) ELISA kit

Additional Materials Required (NOT PROVIDED): 200 µl; anti-ifn-ω monoclonal (murine) antibody Streptavidin-HRP* 150 µl

Rabbit leptin(lep) ELISA Kit

Rat lecithin cholesterol acyltransferase (LCAT) ELISA Kit

KIM-1 ELISA. For the quantitative determination of Kidney Injury Molecule in various biological samples.

Porcine Factor-related Apoptosis(FAS) ELISA Kit

Rat Prolactin ELISA Kit

Human vitamin A (VA) ELISA

CTX-II (Human) ELISA Kit

Resolving immunohematology Case Studies

Human anti-deoxyribonuclease B, anti-dnase B ELISA Kit

For the quantitative determination of IgE in equine serum and plasma. For Research Use Only. Not For Use In Diagnostic Procedures.

Designing the Human Machine Interface of Innovative Emergency Handling Systems in Cars

ab83360 Ammonia Assay Kit

Real Gas Equation of State for Methane

2 Semester Final Exam Study Guide

RayBio Human LBP ELISA Kit

RayBio Human VEGFR1 ELISA Kit

HUMAN MYELOPEROXIDASE

Human 17-Hydroxyprogesterone, 17-OHP ELISA kit

Mouse Platelet Factor 4 (PF4) ELISA

MicroCell User manual

Mouse Tri-iodothyronine, T3 ELISA Kit

genesig Easy q16 Validation kit

Cortisol (Horse) ELISA Kit

Irradiation Effect On Aging Red Blood Cells*

mrna Isolation Kit for Blood/Bone Marrow For isolation mrna from blood or bone marrow lysates Cat. No

Exam: practice test 1 MULTIPLE CHOICE. Choose the one alternative that best completes the statement or answers the question.

IgG (Rabbit) ELISA Kit

Hydrogen Peroxide Colorimetric Detection Kit

camp Direct Immunoassay Kit

IgE (Rat) ELISA Kit. Catalog Number KA assays Version: 05. Intended for research use only.

Title: Department: Previous Version(s): Replaces:

Catalase Fluorometric/Colorimetric Assay Kit

IgE (Dog) ELISA Kit. Catalog Number KA assays Version: 05. Intended for research use only.

RayBio Human Semaphorin 6D ELISA Kit

P a g e 5 1 of R e p o r t P B 4 / 0 9

Isolation o f T Lymphocyte Subsets from Peripheral Blood Using Monoclonal A ntilym phocyte Antibodies*

Human small dense low density lipoprotein(sldl) ELISA Kit

Rat Ferritin ELISA. For the determination of ferritin in serum and plasma of rats. For Research Use Only. Not For Use In Diagnostic Procedures.

RayBio Human B7H1/PD-L1 ELISA Kit

Mouse Lipocalin-2/NGAL ELISA

Monkey Kidney injury molecule 1,Kim-1 ELISA Kit

Human glycated hemoglobin A1c (GHbA1c) ELISA Kit

DRG International, Inc., USA Fax: (908)

A Study of Drink Driving and Recidivism in the State of Victoria Australia, during the Fiscal Years 1992/ /96 (Inclusive)

Effects of Irradiation on Red Cells Stored in CPDA-1 and CPD-ADSOL (AS-1)*

Human arachidonic acid (AA) ELISA Kit

Immunoassay Kit (Colorimetric)

Nitrate Reductase (NR) Colorimetric Assay Kit

Transcription:

ANNALS O F CLINICAL AND LABORATORY S C IEN C E, Vol. 14, No. 5 Copyright 1984, Institute for Clinical Science, Inc. Effect of Methods of Platelet Resuspension on Stored Platelets THOMAS KIRALY, M.A., S.B.B. (ASCP), SUSAN BERNIER, M.S., M.T. (ASCP) S.B.B., R. M. KAKAIYA, M.D., and RITCHARD G. CABLE, M.D. American Red Cross Blood Services, Farmington, CT 06032 ABSTRACT Platelets are prepared from whole blood by differential centrifugation. Following their isolation as a platelet button, platelets are allowed to rest for a short period in the residual plasma before resuspension. In this study, the feasibility of resuspending platelets without this rest period is studied. A total of 35 platelet concentrates (PC) were prepared from blood collected in CPDA-1 and resuspended by one of the following four methods: (1) no resting period, PC placed on a rotator immediately after preparation, (2) a 1.5 hour rest period and gentle shaking prior to rotation, (3) no rest period and immediate gentle shaking prior to rotation, and (4) a 1.5 hour resting phase and no shaking prior to rotation. Following the previous processing, all platelet concentrates were stored for 72 hours on an elliptical platelet rotator at 20 to 24 C to provide continuous agitation. A number of in vitro tests were used as indicators of platelet viability during storage. These included platelet morphology, p 0 2, p C 0 2, ph, osmotic recovery, number of platelets in the concentrate, and platelet volume distribution. O ur findings dem onstrate that platelets are of similar quality after storage in all of the four groups described. Our studies suggest that the resting phase is unnecessary for platelet preparation. The elimination of the resting phase would allow platelet concentrates to be available sooner and improve cost-effectiveness of platelet preparation. Introduction Platelets are generally prepared from anticoagulated whole blood by differential centrifugation.811 The first spin produces platelet rich plasma (PRP) which is transferred to an integrally connected satellite bag. A second spin produces a unit of platelet poor plasma (PPP) and a platelet button. After the removal of all but 50 to 60 ml of PPP, the current general practice is to allow the platelet button to rest undisturbed for 60 to 90 m inutes before resuspension.8 At this point in preparation, the platelet concentrates are then placed in a rotator to allow continuous agitation during storage at room temperature. The rationale for the resting phase in platelet preparation comes from the 366 0091-7370/84/0900-0366 $00.90 Institute for Clinical Science, Inc.

studies performed by Mourad almost 15 years ago.6,7 He reported that the release of platelet enzymes was proportional to the degree of aggregate formation after the centrifugation of platelets. Platelets allowed to rest for 20 to 60 minutes before being rotated were free of aggregates and had decreased enzyme levels when compared to non-rested platelets. More recently, Snyder et al.14 in collaboration with our center, have found that platelets allowed to rest for 90 minutes had a lower B-TG and LDH release at 24 hour storage than platelets not allowed to rest. However, at 72 hour storage, the B-TG and LDH discharge was independent of the rest period. Katz et al.4 have examined immediate resuspension of pheresis platelets by manual agitation and found no detrim ental effect. In previous studies, the effect of a rest period on other parameters, such as ph, morphology, blood gases, and recovery to osmotic stress during storage have not been examined.1 5 9 11,12 Since many of these parameters have been useful in assessing the quality of stored platelets, these studies are perform ed to determine the effect of eliminating the rest period. Materials and Methods P l a t e l e t P r e p a r a t io n Blood from 35 normal blood donors was collected into a closed triple bag system* containing CPDA-1 as anticoagulant. P latelet concentrates were prepared within four hours of blood collection using a centrifuge, f To prepare platelet rich plasma (PRP), the blood was centrifuged at 2800 rpm (2000 X g) for * PL-146, Fenwal, Deerfield, IL. t Sorval RC-3, Sorval, Newtown, CT. $ Fenwal, Deerfield, IL. METHODS OF PLATELET RESUSPENSION 3 6 7 TABLE-I Methods of Platelet Resuspension G roup A * Group B n= 9 Group C n=8 G roup D 1.5 H our r e s t. +. + Manual A g ita tio n - + + - 0.5 Hour r o t a t i o n + + + + *n = Number of samples. 2.7 minutes. To harvest a platelet button from PRP, the PRP was centrifuged at 4200 rpm (4500 x g) for five minutes. All but approximately 60 ml of platelet poor plasma (PPP) was transferred out to another satellite bag, leaving sufficient PPP to resuspend the platelet button. R e s u s p e n s i o n P r o t o c o l s These protocols are presented in table I. As seen in table I, platelet concentrates in the control group (group D) and in Group B were allowed to rest on a flat surface at am bient tem perature for 90 minutes, while platelet concentrates in Group A and C were placed on the rotator im m ediately after preparation. Platelet concentrates in groups B and C were resuspended by gentle manual agitation prior to rotation. All PC were rotated at six rpm on an elliptical rotator^ in an environm entally controlled chamber at 22 to 24 C. S t o r a g e S t u d i e s Following resuspension, platelets were stored as described for 72 hours. At various storage intervals, ph, po, pc 02, platelet morphology score, platelet recovery to osmotic stress, and cell counts were measured as previously described.3 Platelet size distribution was m easured according to the m ethod of Holme et al.2 Significant differences between groups were performed by one way analysis of

3 6 8 KIRALY, BERNIER, KAKAIYA, AND CABLE TABLE I I ph, PO2, and pc02 Measurements on Platelets Stored for 72 Hours Group A G roup B Group C G roup D PH 2 Hour 7. 09±0.01* 7. 06±0.04 7.0 9+ 0.0 3 7. 05±0.05 24 Hour 6. 79±0.43 6. 90±0.14 6. 8 6 ± 0.14 6. 91±0.14 72 Hour 6.77+0.34 6. 74±0.27 6.65±0.34 6. 63±0.39 po2 2 Hour 6 6.9±20.7 4 8.0±13.7 5 1.2±18.4 49.4±32.0 24 Hour 18.3+ 5.0 17.8+ 7.3 19.2+ 6.1 2 6.1±29.3 72 Hour 25.3+16.1 2 2.8±12.1 2 0.3± 6.6 37.4±26.7 PC02 2 Hour 5 8.4± 6.8 6 2.8± 3.8 6 2.6± 5.3 6 5.0± 5.1 24 Hour 7 8.3±14.6 8 3.2±19.8 84.1+15.2 8 2.3±17.5 72 Hour 6 2.9±22.3 7 1.1± 8.6 7 1.4±24.3 76.8± 18.2 * M ean ± 1 S. D. p > 0.05 in a l l com parisons betw een groups. variance and student-n ew m an-k euls test.10 Results During the storage period, there was no difference betw een the groups and the volume of the concentrate (data not shown). The volume of PRP in all concentrates decreased by about 20 percent after 72 hours of storage because of repeated sampling. There was also no statistically significant change in platelet count over the storage period and no statistically significant difference between the groups at any tim e; m ean platelet counts ranged from 0.89 1.2 X 106 per nl ph D u r i n g S t o r a g e As shown in table II, the mean ph at T = 2 for the four groups ranged from 7.05 to 7.09. A decrease in ph occurred during storage in all groups. However, there were no statistically significant differences in ph between the groups at any storage interval. B l o o d G a s e s p 0 2 and pc 02 values during storage are shown in table II. In all groups, there was an initial decline in p 0 2 at 24 hours followed by an increase in p 0 2 at 72 hours. Initially, p C 0 2 increased (at T = 24 hours) but subsequently declined at 72 hours storage in all the groups. There was no statistically significant difference between the groups for p 0 2 or p C 0 2 at any time. P l a t e l e t M o r p h o l o g y D u r in g S t o r a g e Morphology scores for each group at various storage intervals are shown in table III. While morphology declined in each group, there were no statistically significant differences in morphology scores between the groups at any storage interval. R e c o v e r y t o O s m o t ic S t r e s s D u r i n g S t o r a g e The mean ± SD recovery to osmotic stress after 72 hours of storage was as follows: group A = 53.9 ± 15.5 percent, group B = 60.06 ±6.7 percent, group C = 59.0 ± 13.8 percent, and group D = 50.3 ± 11.2 percent. There were no statistically significant differences between the groups. M e d i a n P l a t e l e t V o l u m e D u r i n g S t o r a g e Median platelet volume was measured at T = 0 and T = 72 for each group. The TABLE III Effect of Different Resuspension Methods on Platelet Morphology During 72 Hour Storage S t o r a g e T im e (H o u r s ) G ro u p A * n - 9 G ro u p B G ro u p C n ~ 8 G ro u p D n= 9 2 542±96t 572±54 532±85 577±42 24 576±58 554+49 546+80 586±79 72 532±57 521±76 507+83 522±45 *n = Number o f sa m p le s. tm ean ± 1 S.D. p > 0.0 5 f o r a l l co m p a riso n s betw een g ro u p s.

TABLE IV V a r ia tio n i n th e M edian P l a t e l e t Volume Over 72 Hours of S to rage S t o r a g e Tim e (H o u rs) G roup A * G roup B n - 9 G roup C n=8 G roup D im m ediate 6. 4± 1. Ot 6.6 + 0.6 7.3 ± 0.9 6.9 1 0.8 72 6.4 1 1.4 6.6 + 1.0 7.7 + 1.2 7.4 1 1.9 *n = Number o f sa m p le s. tm ean p l a t e l e t volum e i n f l. ± 1 S.D. p > 0.05 fo r com parisons betw een grou ps. values are shown in table IV. Again, no statistically significant differences were observed. Discussion The purpose of this study was to determine what effect, if any, the elimination of the resting phase during platelet concentrate preparation and resuspension would have on subsequent storage of platelet concentrates. Previous studies have exam ined the release of platelet constituents during p latelet preparation.6,714 A num ber of other in vitro parameters have been studied to delineate further this aspect of platelet preparation. Four resuspension methods have been investigated, two of which utilized a rest period and two which did not. One group of platelet concentrates was resuspended after the rest period with gentle manual agitation while the other group of PC was simply placed on a mechanical rotator after the rest period. Similarly, in platelet concentrates in which no rest period was allowed, one group was resuspended manually prior to rotation and the other group simply placed on a rotator. Our studies show that the ph was well maintained during 72 hours of storage, regardless of how platelets were resuspended. P latelet m orphology and re covery to osmotic stress were also well m aintained over the storage interval. Changes in p 0 2 and p C 0 2 w ere in d e METHODS OF PLATELET RESUSPENSION 3 6 9 pendent of resuspension method and are sim ilar to those reported previously.3 Volume distribution curves w ere also comparable in all four groups. These results show that there are no discernable ill effects of om itting the resting phase from platelet preparation and no appreciable benefit to manual agitation prior to rotation. The rationale for using a rest period after platelets are harvested has been to facilitate a smooth resuspension of platelets. Although aggregates were not quantitated in platelet concentrates, visual inspection of platelet concentrations after preparation and during storage showed no differences among the groups for the presence of gross aggregates. In addition, in vitro tests done during storage showed platelets to be of similar quality for all resuspension methods. These findings suggest that any one of the protocols used for resuspension may be suitable for platelet preparation. The protocol that eliminates the rest period and does not require manual agitation is desirable for logistical reasons. This would simplify the preparation protocol as well as allow the availability of processed platelets sooner than if a 90 minute rest period was used. Our studies were confined to the assessment of in vitro properties of platelets during storage; studies of the in vivo hemostatic effectiveness of platelets resuspended by different methods are indicated. References 1. H a n d i n, R. I., F o r t i e r, N. L., and V a l e r i, C. R.: Platelet response to hypotonic stress after storage at 4 C or 22 C. Transfusion 10:305-309, 1970. 2. H o l m e, S., V aidja, K., and M u r p h y, S.: Platelet storage at 22 C: Effect of type of aggregation on morphology, viability and function in vitro. Rlood 52:425-435, 1978. 3. K akaiya, R. M., and K a t z, A. J.: Platelet preservation in large containers. Vox Sang, (in press). 4. K a t z, A. J., G e n c o, P. V., B l u m b e r c, N., S n y d e r, E. L., C a m p, B., and M o r s e, E. E.: Platelet collection and transfusion using the

37 0 KIRALY, BERNIER, KAKAIYA, AND CABLE Fenwal CS-3000 cell separator. Transfusion 10. Nie, N. H., H ull, C. H., Jenkins, J. G., Stein- 21:560-563, 1981. brenner, K., and Bent, D. H.: Statistical 5. K unicki, R. J., T u c e l l i, M., B e c k e r, G., and Package for the Social Sciences, 2nd ed. New Aster, R. H.: A study of variables affecting the York, McGraw-Hill, 1975. quality of platelets stored at room temperature. Transfusion 15:414 421, 1975. covery of platelets in platelet rich plasma by sim 11. R eiss, R. F. and K at z, A. J.: Optimizing re 6. M o u r a d, N.: A simple method for obtaining plex strategy. Transfusion 16:370 375:1975. platelet concentrations free of aggregates. Transfusion 8:48, 1968. 12. R o c k,g. and F i g u e r e d o,a.: Metabolic changes 7. M o u r a d, N.: Studies on release of certain enzymes from human platelets. Transfusion 1976. during platelet storage. Transfusion 16:17-19, 8 : 3 6 3-6 7, 1 9 6 8. 13. Sl i c h t e r, S. J., and H a r k e r, L. A.: Preparation 8. M iller, W. V : Technical Manual of the AABB, and storage of platelet concentrates. Transfusion 7th ed. Washington, American Association of i6:8-12, 1976. Blood Banks, 1974, pp. 43-44. 14. Sn y d e r, E. L., H e z z e y, A., K a t z, A. J., and 9. M u r p h y, S., Sa y a r, S., and G a r d n e r, F.: Storage B o c k, J.: Occurrence of the release reaction of platelet concentrates at 22 C. Blood 35:549- during preparation and storage of platelet concentrates. Vox Sang. 41:172 77, 557, 1979. 1981.